Literature DB >> 30395447

siRNA Delivery Using Dithiocarbamate-Anchored Oligonucleotides on Gold Nanorods.

Jianxin Wang1, Mini Thomas1, Peng Lin1,2, Ji-Xin Cheng1,2, Daniela E Matei3,4, Alexander Wei1,5.   

Abstract

We present a robust method for loading small interfering RNA (siRNA) duplexes onto the surfaces of gold nanorods (GNRs) at high density, using near-infrared laser irradiation to trigger their intracellular release with subsequent knockdown activity. Citrate-stabilized GNRs were first coated with oleylsulfobetaine, a zwitterionic amphiphile with low cytotoxicity, which produced stable dispersions at high ionic strength. Amine-modified siRNA duplexes were converted into dithiocarbamate (DTC) ligands and adsorbed onto GNR surfaces in a single incubation step at 0.5 M NaCl, simplifying the charge screening process. The DTC anchors were effective at minimizing premature siRNA desorption and release, a common but often overlooked problem in the use of gold nanoparticles as oligonucleotide carriers. The activity of GNR-siRNA complexes was evaluated systematically against an eGFP-producing ovarian cancer cell line (SKOV-3) using folate receptor-mediated uptake. Efficient knockdown was achieved by using a femtosecond-pulsed laser source to release DTC-anchored siRNA, with essentially no contributions from spontaneous (dark) RNA desorption. GNRs coated with thiol-anchored siRNA duplexes were less effective and also permitted low levels of knockdown activity without photothermal activation. Optimized siRNA delivery conditions were applied toward the targeted knockdown of transglutaminase 2, whose expression is associated with the progression of recurrent ovarian cancer, with a reduction in activity of >80% achieved after a single pulsed laser treatment.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30395447      PMCID: PMC6740333          DOI: 10.1021/acs.bioconjchem.8b00723

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  7 in total

Review 1.  Gold nanoparticles in virus detection: Recent advances and potential considerations for SARS-CoV-2 testing development.

Authors:  Jianxin Wang; Adam J Drelich; Caroline M Hopkins; Sandro Mecozzi; Lingjun Li; Glen Kwon; Seungpyo Hong
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-09-08

Review 2.  Functionalized gold nanostructures: promising gene delivery vehicles in cancer treatment.

Authors:  Sanjay Kumar; Anchita Diwan; Parinita Singh; Shikha Gulati; Devanshu Choudhary; Ayush Mongia; Shefali Shukla; Akanksha Gupta
Journal:  RSC Adv       Date:  2019-08-01       Impact factor: 4.036

3.  Photoresponsive miR-34a/Nanoshell Conjugates Enable Light-Triggered Gene Regulation to Impair the Function of Triple-Negative Breast Cancer Cells.

Authors:  Megan N Dang; Carolina Gomez Casas; Emily S Day
Journal:  Nano Lett       Date:  2020-12-11       Impact factor: 11.189

Review 4.  Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery.

Authors:  Wanyi Tai
Journal:  Molecules       Date:  2019-06-13       Impact factor: 4.411

5.  Paper-based genetic assays with bioconjugated gold nanorods and an automated readout pipeline.

Authors:  Claudia Borri; Sonia Centi; Sofia Chioccioli; Patrizia Bogani; Filippo Micheletti; Marco Gai; Paolo Grandi; Serena Laschi; Francesco Tona; Andrea Barucci; Nicola Zoppetti; Roberto Pini; Fulvio Ratto
Journal:  Sci Rep       Date:  2022-04-13       Impact factor: 4.379

Review 6.  Gold nanoparticle‑mediated delivery of paclitaxel and nucleic acids for cancer therapy (Review).

Authors:  Zhiguang Wang; Jianyu Dong; Qiaojiajie Zhao; Ying Ying; Lijie Zhang; Junrong Zou; Shuqi Zhao; Jiuju Wang; Yuan Zhao; Shanshan Jiang
Journal:  Mol Med Rep       Date:  2020-10-11       Impact factor: 2.952

Review 7.  Gold Nanoparticles for Vectorization of Nucleic Acids for Cancer Therapeutics.

Authors:  Daniela Ferreira; David Fontinha; Catarina Martins; David Pires; Alexandra R Fernandes; Pedro V Baptista
Journal:  Molecules       Date:  2020-07-31       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.